Denmark has stopped after the death of a vaccinated person caused by a serious blood clot, a gesture that was followed hours later by Norway and Iceland, as a precautionary measure. This Friday they were imitated by Bulgaria, alleging the same reason. They are the last countries to join the decision of Austria, which has detected the death of a nurse and three serious reactions due to thrombosis after being administered this vaccine. Spain, however, has confirmed that .
Luxembourg, Latvia, Estonia and Lithuania have also opted to stop vaccinating with the British pharmaceutical antidote until the European Medicines Agency studies the situation in depth and provides more information. The Spanish Minister of Health, Carolina Darias, has confirmed that this morning a meeting of experts from this institution is taking place at its headquarters in Amsterdam to analyze the situation in depth.
The EMA has assured that it could issue “today or tomorrow” advice on the use of the drug in the European Union, although, for the time being and after studying the cases reported by Austria, it does not warn of a causal relationship between the anti-cancer drug AstraZeneca covid and thrombosis. In Austria, a young nurse has died for this reason ten days after receiving the vaccine. Another person is hospitalized after experiencing a pulmonary embolism caused by a blood clot; and two other cases, who also received an antidote from the same batch of vaccines, have suffered episodes of thrombosis and embolism.
After Denmark’s announcement, the United Kingdom has come out to defend the efficacy of the vaccine developed by AstraZeneca in collaboration with the University of Oxford, and with which the entire British population is being vaccinated. “We have made it clear that the vaccine is both safe and effective…and when people are called upon to administer it, they should do so with confidence,” Prime Minister Boris Johnson said.
No notification of thrombosis in Spain
“In Spain, no effect of this type of thrombotic events has been reported. In relation to other things, such as headaches, pain in the area and intestinal disorders,” Darias explained in La Sexta. The minister has asked for caution, has insisted that “we are in good hands” and has assured that a causal relationship between the events in Denmark and Austria and the Oxford University vaccine has not yet been established.
In none of the cases of the victims has it been possible to prove, for the moment, the direct relationship between the thrombi and the injection against covid-19. This was reported by the European Medicines Agency itself this Wednesday in relation to adverse reactions in Austria. Not even his vaccine.
The Austrian Government linked all the incidents to a batch of AstraZeneca’s vaccine, ABV5300, delivered to 17 EU countries and made up of one million doses of the antidote. After the first examination of the safety committee, the EMA explained that it will continue to explain the causes of these blood clots, but warned that the number of people who have suffered from these thrombi is not significant in relation to the general prevalence in the population.
Caution is required
However, the link in several cases between the administration of the immunizing serum and death from thrombi days later has put these countries on alert, which have preferred to stop the process and go to the European Medicines Agency in search of answers.
“We do not yet know if the blood clots and the death of a citizen are due to the vaccine, but now it must be thoroughly examined for safety reasons,” said Tanja Erichsen, director of the department of the Danish Medicines Agency, as collected. Politiken newspaper.
The Danish health authorities have assured that the decision has been difficult, especially at a time when the vaccination plan needs all the vaccines that may be available to continue immunizing the population. “But precisely because we vaccinate so many, we must also respond with timely care when potential serious side effects become known. We need to clarify this before we can continue to use AstraZeneca’s vaccine,” confirmed Søren Brostrøm, spokesman for the Ministry of Health.
Facebook Comments
Disqus